Please rate this video

IMW 2019 | Changing perceptions of MGUS progression: explaining the data

Please rate this video

Ola Landgren

Ola Landgren, MD, PhD, of Memorial Sloan Kettering Cancer Center, New York, NY, discusses his research into the progression of monoclonal gammopathy (MGUS) into multiple myeloma (MM), and the findings which indicate that risk assessment needs to be carried out more frequently. He also highlights how not all MGUS goes through a smoldering myeloma phase. This interview took place at the International Myeloma Workshop (IMW) 2019, in Boston, MA.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter